Which describes you?


Product?

Do you need to know more about what we offer for each of our products?

Do you want to know more about LUCENTIS Access Solutions? To see what we offer, click here.

The information contained in this section of the site is for U.S. health care professionals only. Please click "OK" if you are a U.S. health care professional.

The link you selected will take you away from this site to one that is not owned or controlled by Genentech. Genentech is not part of the site. Nor does it control the content. Genentech does not guarantee the information on the page. Your use of third-party websites is at your own risk and is subject to the terms and conditions of use for such sites. 


Contact Us


LUCENTIS Access Solutions
1 DNA Way, Mail Stop #858a
South San Francisco, CA 94080-4990
Phone: (866) 724-9394
Fax: (866) 724-9412
Main website: LUCENTISAccessSolutions.com
  
General inquiries, comments and feedback about technical issues involving the Access Solutions websites can be emailed to info@genentechaccesssolutions.com. Due to security concerns, we are unable to download or read email attachments. We will not accept email communication involving patient information.
 
Genentech® Access to Care Foundation
1 DNA Way, Mail Stop #858a
South San Francisco, CA 94080-4990
Phone: (800) 232-0592
Fax: (888) 727-7773
 
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990
Phone: (650) 225-1000
Main website: www.gene.com

Who is LUCENTIS for?

LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with Wet Age-Related Macular Degeneration (AMD) and Macular Edema Following Retinal Vein Occlusion (RVO).

What important safety information should I know about LUCENTIS?

LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious eye infections. LUCENTIS should not be used in patients who have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. LUCENTIS patients have had increases in eye pressure within 1 hour of an injection. Serious side effects also include inflammation inside the eye, and rarely, problems related to the injection procedure, such as cataracts. Although not common, some LUCENTIS patients have had strokes or heart attacks. If your eye becomes red, sensitive to light, painful, or has a change in vision, you should call or visit your eye doctor right away. Ask your doctor if you have questions or want more information.

For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.

LUCENTIS® is a registered trademark and the Access Solutions logo and the Access Solutions Treatment made possible logo are trademarks of Genentech USA, Inc.

© 2010 Genentech USA, Inc. All rights reserved. This site is intended for U.S. residents only.